Umbhali: Janice Evans
Umhla Wokudalwa: 27 Eyekhala 2021
Hlaziya Umhla: 16 Eyenkanga 2024
Anonim
bifidobacteria
Ividiyo: bifidobacteria

Umxholo

I-Bifidobacteria liqela leebhaktiriya ezihlala zihlala emathunjini. Zingakhula ngaphandle komzimba emva koko zithathwe ngomlomo njengeyeza.

I-Bifidobacteria iqhele ukusetyenziselwa urhudo, ukuqhina, ukuphazamiseka kwamathumbu okubizwa ngokuba kukucaphuka kwesisu, ukuthintela ukubanda okanye umkhuhlane, kunye nezinye iimeko, kodwa akukho bungqina benzululwazi bokuba uxhase uninzi lwezi zinto zisetyenziswayo.

Isifo seCoronavirus 2019 (COVID-19): Akukho bungqina bokuba uxhase usebenzisa i-bifidobacteria ye-COVID-19. Landela ukhetho lokuphila olusempilweni kunye neendlela zothintelo eziqinisekisiweyo endaweni yoko.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe IBIFIDOBACTERIA zezi zilandelayo:

Inokwenzeka ukuba isebenze ...

  • Ukuqunjelwa. Uninzi lophando lubonisa ukuba ukuthatha i-bifidobacteria kunokunyusa ukushukuma kwamathumbu malunga nesihlalo esi-1.5 ngeveki kubantu abanokuqunjelwa. Kodwa ayizizo zonke iintlobo ze-bifidobacteria ezibonakala ngathi ziyasebenza.
  • Usulelo lokugaya olunokukhokelela kwizilonda (Helicobacter pylori okanye H. pylori). Ukuthatha i-bifidobacteria kunye ne-lactobacillus kunye nonyango oluqhelekileyo H. pylori kunokunceda ekupheliseni usulelo lwe-p. Pylori malunga nokuphindaphinda kabini kunye nokuthatha unyango oluqhelekileyo H. pylori kuphela. Inokunciphisa iziphumo ebezingalindelekanga ezinjengorhudo kunye nencasa embi kwiyeza likaH. Pylori.
  • Ingxaki yexesha elide yamathumbu amakhulu ebangela iintlungu zesisu (isifo esiswini esinokucaphuka okanye i-IBS). Uninzi lophando lubonisa ukuba ukuthatha i-bifidobacteria kwiiveki ezi-4 ukuya kwezi-8 kunokunciphisa iimpawu ze-IBS ezinjengeentlungu zesisu, ukudumba, kunye nobunzima bokuhamba kwamathumbu. Inokunciphisa iimpawu ezinje ngoxinzelelo kunye noxinzelelo kubantu abane-IBS. Kodwa ayizizo zonke iintlobo ze-bifidobacteria ezibonakala ngathi ziyasebenza.
  • Ingxaki emva kotyando lwe-ulcerative colitis (pouchitis). Ukuthatha indibaniselwano ye-bifidobacteria kunye ne-lactobacillus, kunye okanye ngaphandle kwe-streptococcus, ngomlomo kubonakala ngathi kunceda ukukhusela i-pouchitis emva kotyando lwe-ulcerative colitis.
  • Usulelo lweendlela zomoya. Uninzi lophando lubonisa ukuba ukusebenzisa iiprobiotiki eziqukethe i-bifidobacteria kunceda ukuthintela usulelo lomoya njengokubanda okuqhelekileyo kubantu abasempilweni, kubandakanya abantwana abasesikolweni kunye nabafundi beekholeji. Kodwa ukuthatha i-bifidobacteria akubonakali kunciphisa umngcipheko wosulelo lomoya kubantwana abasesibhedlele nakwishumi elivisayo okanye kubantu abadala abakhathalelayo.
  • Urhudo olubangelwa yi-rotavirus. Ukunika iintsana ezinesifo sorhudo se-bifidobacteria kunokunciphisa ixesha lokurhuda malunga nosuku olunye.
  • Urhudo lwabahambi. Ukuthatha i-bifidobacteria kunceda ukuthintela urhudo lwabahambi xa kusetyenziswa ezinye iiprobiotic ezinjenge-lactobacillus okanye i-streptococcus.
  • Uhlobo lwesifo sokukrala kwamathumbu (ulcerative colitis). Uphando lubonisa ukuba ukuthatha iiprobiotic eziqukethe i-bifidobacteria kunye ne-lactobacillus kunye ne-streptococcus kunokunceda ukunyusa izinga lokuxolelwa phantse phantse kabini kubantu abane-ulcerative colitis. Nangona kunjalo, uninzi lophando lubonisa ukuba i-bifidobacteria ayiloncedo ekuthinteleni ukubuyela umva.

Kusenokwenzeka ukuba ayisebenzi ...

  • Yehla kwimemori nakwizakhono zokucinga ezenzeka ngesiqhelo ngobudala. I-Bifidobacteria ibonakala ngathi ayiphuculi izakhono zokucinga kunye nememori kubantu abadala ngokuhla okuqhelekileyo kwizakhono zokucinga.
  • Usulelo lwe-gastrointestinal tract yi-bacteria ebizwa ngokuba yiClostridium difficile. Uninzi lophando lubonisa ukuba ukuthatha i-bifidobacteria kunye namanye ama-probiotic akuthinteli isifo sohudo esibangelwa lusulelo lweClostridium difficile.
  • Ukukhula komntwana. Ukunika ifomula equlethe i-bifidobacteria kunye ne-lactobacillus akukuphuculi ukukhula kweentsana.
  • Ukutyeba kakhulu. Uninzi lophando lubonisa ukuba ukuthatha i-bifidobacteria ukuya kuthi ga kwiinyanga ezi-6 akuphuculi ukunciphisa umzimba kubantu abatyebe kakhulu okanye abatyebe kakhulu.
  • Usulelo lwegazi (sepsis). Ukongeza i-bifidobacteria kwifomula yeentsana akuthinteli i-sepsis kwiintsana ezizelwe ngaphambi kwexesha.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

  • Urhudo kubantu abathatha amayeza okubulala iintsholongwane. Uphando lubonisa ukuba ukuthatha i-bifidobacteria kunye namayeza okubulala iintsholongwane kunokunciphisa amathuba orhudo malunga neepesenti ezingama-45. Kodwa ezinye iziphumo ezingqubanayo zikhona. Kungenzeka ukuba i-bifidobacteria inokuthintela urhudo olubangelwa ngamanye amayeza okubulala iintsholongwane kodwa hayi amanye. Kwakhona, i-bifidobacteria inokusebenza ngcono xa isetyenziswe kwindibaniselwano ethile kunye ne-lactobacillus kunye ne-streptococcus. Kodwa ayisiyiyo yonke indibaniselwano ebonakala ngathi iyasebenza.
  • Ukusebenza kwezemidlalo. Uphando lwakwangoko lubonisa ukuba ukuthatha i-bifidobacteria kunceda iimbaleki eziqeqeshiweyo ukuba ziqhubele phambili ngexesha elifanayo.
  • I-eczema (i-atopic dermatitis). Olunye uphando lubonisa ukuba ukunika i-bifidobacterium kwiintsana kunokunceda UKUPHATHA i-eczema, kodwa iziphumo ezingqubanayo zikhona. Olunye uphando lubonisa ukuba ukunika i-bifidobacteria kunye ne-lactobacillus kubafazi abakhulelweyo kwiinyanga ezi-2 zokugqibela zokukhulelwa, nokunikezela usana kwiinyanga ezimbini zokuqala emva kokuzalwa, kunokunceda UKUTHINTELA i-eczema. Kodwa iziphumo ezingqubanayo zikhona. Ukunika i-bifidobacteria kunye ne-lactobacillus kwiintsana ezisemngciphekweni kuphela kwiinyanga ezi-6 zokuqala zobomi ayikuthinteli i-eczema.
  • Isifo seCeliac. Uphando lwakwangoko lubonisa ukuba ukuthatha i-bifidobacteria njengenxalenye yokutya okungenagluten akuphuculi zimpawu zesisu kunye namathumbu xa kuthelekiswa nokutya kuphela kubantwana abanesifo se-celiac esisandula ukufunyanwa.
  • Ukuhla kwenkumbulo kunye nezakhono zokucinga kubantu abadala ezingaphezulu kokuqhelekileyo kubudala babo. Olunye uphando lubonisa ukuba ukuthatha i-bifidobacteria kuphucula inkumbulo kubantu abanokwehla kwezakhono zokucinga, kodwa kubonakala ngathi akuncedi ngolwimi okanye ukukwazi ukuhoya.
  • Ipleyiti yamazinyo. Uphando lwakwangoko lubonisa ukuba ukutya iyogathi yeziqhamo kunye ne-bifidobacteria yeeveki ezi-2 akukunciphisi ukubekwa kwamazinyo ebantwaneni.
  • Urhudo. Uphando lwakwangoko lwafumanisa ukuba ukongeza i-bifidobacteria kwi-Saccharomyces boulardii kunxulunyaniswa nokuqhubela phambili kwesifo sorhudo ebantwaneni ngesi sifo ngokukhawuleza.
  • Ukunyuka komzimba kwi-pollen yaseJapan. Olunye uphando lubonisa ukuba ukuthatha i-bifidobacteria ngexesha le-pollen kunciphisa impumlo kunye neempawu zamehlo e-cedar pollen yaseJapan. Kodwa iziphumo ezingqubanayo zikhona. I-Bifidobacteria ayikhombisi ukunciphisa ukuthimla okanye iimpawu zomqala ezinxulunyaniswa ne-pollen yaseJapan.
  • Isifo esibi emathunjini kwiintsana ezingaphambi kwexesha (i-necrotizing enterocolitis okanye i-NEC). Uphando lubonisa ukuba ukunika i-bifidobacteria yodwa kwiintsana ezizelweyo ayikuthinteli le meko. Kodwa ukunika i-bifidobacteria nge-lactobacillus kunokuba nesibonelelo esincinci.
  • Isigulo esibi esibangelwa kukuvezwa yimitha. Uphando lwakwangoko lubonisa ukuba i-bifidobacteria enganyangekiyo yeantibiotic inokunceda ekuphuculeni ukusinda kwexeshana kunyango lwezifo zemitha. Ngokudibanisa namayeza okubulala iintsholongwane, i-bifidobacteria ibonakala ngathi iyanceda ukukhusela ibhaktheriya eyingozi ekukhuleni kwaye ibangele isifo esibi.
  • Isifo samathambo (RA).
  • Usulelo lwezintso, isinye, okanye i-urethra (usulelo lwe-urinary tract okanye i-UTIs).
  • Ukwaluphala.
  • Intlungu yesifuba, mhlawumbi ngenxa yosulelo (isifo sokukrala kwebele).
  • Umhlaza.
  • Ukuxhuzula.
  • Usulelo kubantu abaphathwe ngamachiza omhlaza.
  • Ukukhula komntwana.
  • Ukukhula kunye nokukhula kweentsana ngaphambi kwexesha.
  • Ukunciphisa okanye ukuvala ukuhamba kwe-bile kwisibindi (cholestasis).
  • Seswekile.
  • Ukunganyamezelani kweLactose.
  • Iingxaki zesibindi.
  • Isifo seLyme.
  • Uqhekeko.
  • Ubuhlungu bemisipha obubangelwa kukuzilolonga.
  • Amanqanaba aphezulu e-cholesterol okanye amanye amafutha (lipids) egazini (hyperlipidemia).
  • Ukudumba (ukudumba) nokwakha amanqatha esibindini ebantwini abasela utywala obuncinci okanye bangaseli (nonalcoholic steatohepatitis or NASH).
  • Ukudumba (ukudumba) kunye nezilonda ngaphakathi emlonyeni (i-mucositis yomlomo).
  • Urhudo olubangelwa lonyango lwemitha.
  • Ukutshintsha iibacteria eziluncedo zisuswe sisifo sorhudo.
  • Iingxaki zesisu.
  • Ukuthintela.
  • Ezinye iimeko.
Ubungqina obungakumbi buyafuneka ukukala i-bifidobacteria kwezi zinto zisetyenziswayo.

Iintsholongwane ezininzi kunye nezinye izinto zihlala emizimbeni yethu ngesiqhelo. Iintsholongwane "ezinobungane" ezinje nge bifidobacteria zinokusinceda ukuba sihlule ukutya, sifumane izakhamzimba, kwaye silwe nezinto "ezingathandaniyo" ezinokubangela izifo ezinje ngesifo sorhudo.

Xa kuthathwa ngomlomo: Bifidobacteria zezi NGOKUKHUSELEKILEYO kubantu abadala abasempilweni xa bethathwe ngomlomo ngokufanelekileyo. Abanye abantu, unyango lwe-bifidobacteria lunokucaphukisa isisu kunye namathumbu, kubangele urhudo, ukuqunjelwa kunye negesi.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Uhlobo oluthile lwe-bifidobacteria, Bifidobacterium bifidum, yi UKHUSELEKO OLUNOKWENZEKA xa kuthathwe ngomlomo ngokufanelekileyo iiveki ezi-6 ngelixa ukhulelwe. Akukho lwazi lwaneleyo lwaneleyo malunga nokhuseleko lokuthatha ezinye iintlobo ze-bifidobacteria ukuba ukhulelwe okanye uncancisa. Hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa.

Abantwana: Bifidobacteria zezi NGOKUKHUSELEKILEYO yabantwana abathandanayo xa bethathwe ngomlomo ngokufanelekileyo. Nangona kukho iimeko zosulelo lwegazi kunye ne-bifidobacteria kwiintsana ezigula kakhulu, la matyala anqabile.

Amandla omzimba abuthathaka: Kukho inkxalabo yokuba "iiprobiotic" zinokukhula kakuhle kakhulu kubantu abanamajoni omzimba abuthathaka kwaye zibangele usulelo. Nangona oku kungenzekanga ngokuthe ngqo nge-bifidobacteria, kuye kwakho iimeko ezinqabileyo ezibandakanya ezinye iintlobo zeprobiotic ezinjengeLactobacillus. Ukuba unamajoni omzimba abuthathaka (umzekelo, une-HIV / AIDS okanye unyangwa ngumhlaza), jonga umboneleli wakho wezempilo ngaphambi kokusebenzisa i-bifidobacteria.

Ukuvaleka emathunjini: Amatyala amabini osulelo lwegazi axeliwe kwiintsana ezinikwe i-bifidobacteria probiotic. Kuzo zombini iimeko, iintsana ziye zahlinzwa isisu. Kucingelwa ukuba usulelo lwegazi lubangelwe kukuvaleka kwamathumbu okubangelwe lutyando lwesisu, olwavumela i-bifidobacteria ukuba iwele iye egazini. Kwimeko enye, ukuthatha i-bifidobacteria emva kokulungiswa kwamathumbu emathunjini kwakungakhange kubangele olunye usulelo lwegazi. Ke ngoko umngcipheko wosulelo lwegazi ayisiyiyo inkxalabo kubantwana abaninzi abathatha i-bifidobacteria. Kodwa i-bifidobacteria kufuneka isetyenziswe ngononophelo okanye ithintelwe kwiintsana ezinezisu okanye isisu.

Iphakathi
Lumka ngale nhlanganisela.
Iziyobisi Antibiotic
Amayeza okubulala iintsholongwane asetyenziselwa ukunciphisa iintsholongwane eziyingozi emzimbeni. Amayeza okubulala iintsholongwane anokunciphisa neentsholongwane ezinobungane emzimbeni. I-Bifidobacteria luhlobo lweebacteria ezinobuhlobo. Ukuthatha ii-antibiotics kunye ne-bifidobacteria kunokunciphisa ukusebenza kwe-bifidobacteria. Ukuthintela oku kunxibelelana, thatha iimveliso ze-bifidobacteria ubuncinci iiyure ezimbini ngaphambi okanye emva kwentsholongwane.
Akukho kunxibelelana kwaziwayo kunye namayeza kunye nezongezo.
Akukho kunxibelelana kwaziwayo nokutya.
La machiza alandelayo afundwe kuphando lwezesayensi:

ABADALA

NGOMLOMO:
  • Ukuqunjelwa: I-100 yezigidi ukuya kwi-20 yezigidigidi zokwenza iikholoni ze-bifidobacteria zisetyenzisiwe mihla le. Kwiimeko ezininzi, i-bifidobacteria ithathwa yonke imihla iiveki ezi-1-4. Ngamanye amaxesha i-5-60 yezigidigidi zeeyunithi zokwenza i-bifidobacteria kunye ne-lactobacillus zithathiwe yonke imihla kwiveki e-1 ukuya kwinyanga enye.
  • Ukuphazamiseka kwexesha elide kwamathumbu amakhulu abangela iintlungu zesisu (isifo esiswini esinokucaphuka okanye i-IBS)Ukuphucula iimpawu zesisu kunye namathumbu, i-100 yezigidi ukuya kwi-1 yezigidigidi zokwenza iikholoni ze-bifidobacteria kusetyenziswe yonke imihla kwiiveki ezi-4 ukuya kwezi-8. Kwakhona, iiyunithi ezi-5 zezigidi zeekoloni zokwenza i-bifidobacteria kunye ne-lactobacillus kunye ne-streptococcus zisetyenziswe kabini imihla ngemihla kwiiveki ezi-4. Ukuphucula ukudakumba noxinzelelo kubantu abane-IBS, iiyunithi ezili-10 zezigidi zekoloni ezenza ibifidobacteria zisetyenziswe kanye yonke imihla kwiiveki ezi-6.
  • Usulelo lomoya: Iibhiliyoni ezi-3 zokwenza iiyunithi ze-bifidobacteria zisetyenzisiwe mihla le kwiiveki ezi-6.
  • Kwingxaki emva kotyando lwe-ulcerative colitis (pouchitis)Idosi ukuya kuthi ga kwi-3 trillion yeeyunithi zokwenza i-bifodobacteria kunye ne-lactobacillus kunye ne-streptococcus inikwe kube kanye yonke imihla ukuya kwiinyanga ezili-12.
  • Ukusuleleka kwintsholongwane engakhokelela kwizilonda (Helicobacter pylori okanye H. pylori): Iibhiliyoni ezi-5 zokwenza iicolony ze-bifidobacteria kunye ne-lactobacillus mihla le kwiveki e-1 ngexesha lonyango lwe-H.pylori kunye neveki enye emva koko isetyenzisiwe.
  • Kuhlobo lwesifo sokukrala kwamathumbu (ulcerative colitis)Ukunyusa uxolelo, iigrama ezi-3 ezilingana neebhiliyoni ezingama-900 zeeyunithi zokwenza i-lactobacillus kunye ne-bifidobacteria kunye ne-streptococcus zisetyenziswe kube kanye okanye kabini yonke imihla.
ABANTWANA

NGOMLOMO:
  • UkuqunjelwaIiyunithi ezenza i-bifidobacteria ye-bhiliyoni yeebhiliyoni yonke imihla iiveki ezi-4 isetyenzisiwe kubantwana abaneminyaka emi-3-16 ubudala.
  • Ingxaki yexesha elide yamathumbu amakhulu ebangela iintlungu zesisu (isifo esiswini esinokucaphuka okanye i-IBS)Iibhiliyoni ezili-10 zokwenza iiyunithi ze-bifidobacteria yonke imihla kwiiveki ezi-4 zisetyenzisiwe.
  • Usulelo lomoyaI-2-10 yezigidigidi zeeyunithi zokwenza iikholoni zokudibanisa i-bifidobacteria kunye ne-lactobacillus zisetyenziswe kabini yonke imihla kubantwana abaneminyaka emi-3 ukuya kweli-13.
  • Isifo sohudo esibangelwa yi-rotavirus: I-Bifidobacteria, kunye okanye kunye ne-streptococcus, sele isetyenzisiwe ebantwaneni ukuya kuthi ga kwiminyaka emi-3 ubudala. Kwakhona, i-bifidobacteria kunye ne-lactobacillus isetyenziswe kabini imihla ngemihla iintsuku ezi-3.
  • Kuhlobo lwesifo sokukrala kwamathumbu (ulcerative colitis): Ukufikelela kwi-1.8 yezigidi zezigidi zeekoloni ezenza i-bifidobacteria kunye ne-lactobacillus kunye ne-streptococcus isetyenzisiwe yonke imihla ukuya kunyaka-1 kubantwana abaneminyaka eli-1-16 ubudala.
B. Bifidum, B. Breve, B. Infantis, B.ilactis, B. Longum, Bifido, Bifido Bacterium Longum, Bifidobacterias, Bifidobactérie, Bifidobactéries, Bifidobacterium, Bifidobacterium osemtsha; Bifidobacterium animalis, Bifidobacterium bifidum; IBifidobacterium breve; IBifidobacterium infantis; IBifidobacterium lactis; Bifidobacterium longum, Bifidum, Bifidus, Bifidus Brevis, Bifidus Infantis, Bifidus Longum, Bifidobacteria Bifidus, Lactobacillus Bifidus, L. Bifidus, Probiotic, Probiotique.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.


  1. UAthalye-Jape G, Minaee N, uNathan E, et al. Iziphumo zokuqala kwangaphambi kwexesha elincinci xa kuthelekiswa nokufaneleka kweentsana zokukhulelwa emva kweBifidobacterium breve M-16 V yokuncedisa. J Umama okhulayo umntwana osandul 'ukuzalwa. Ngo-2020; 33: 2209-2215. Jonga i-abstract.
  2. Wu G, Chen X, Cui N, et al. Isithintelo se-Bifidobacterium supplementation kwi-neonatal cholestasis kwi-preterm neonates enobunzima bokuzalwa obuphantsi. Ukuziqhelanisa neGastroenterol Res. Ngo-2020; 2020: 4625315. Jonga i-abstract.
  3. UXiao J, uKatsumata N, uBernier F, et al. Iprobiotic bifidobacterium breve ekuphuculeni imisebenzi yokuqonda yabantu abadala abanesikrokro sokukhubazeka kwengqondo esingaqondakaliyo: Isilingo esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo. J iAlzheimers Dis. 2020; 77: 139-147. Jonga i-abstract.
  4. ILin CL, Hsu YJ, Ho HH, et al. IBifidobacterium longum subsp. Ukuxhaswa kwe-longum OLP-01 ngexesha lokunyamezela ukuqhuba uqeqesho kuphucula ukusebenza komthambo phakathi kwabagijimi abaphakathi kunye nabakude: Ityala elilawulwa yimfama kabini. Izondlo. Ngo-2020; 12: 1972. Jonga i-abstract.
  5. U-Lewis ED, u-Antony JM, uCrowley DC, et al. Ukusebenza kweLactobacillus paracasei HA-196 kunye neBifidobacterium longum R0175 ekunciphiseni iimpawu zesifo samathumbu (IBS): Isifundo esilawulwa ngokungahleliwe, esilawulwa yi-placebo. Izondlo. Ngo-2020; 12: 1159. Jonga i-abstract.
  6. UMichael DR, uJack AA, uMasetti G, et al. Uphononongo olulawulwa ngokungacwangciswanga lubonisa ukongezwa kwabantu abadala abatyebe kakhulu kwaye batyebe nge-lactobacilli kunye ne-bifidobacteria inciphisa ukutyeba komzimba kunye nokuphucula impilo. Inzululwazi. 20; 10: 4183. Jonga i-abstract.
  7. UCzajeczny D, Kabzi & nacute; ska K, Wójciak RW. Ngaba iprobiotic supplementation inceda ukunciphisa umzimba? Isifundo esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo kunye neBifidobacterium lactis BS01 kunye neLactobacillus acidophilus LA02. Yitya ukungahambi kakuhle. 2020. Jonga okungaqondakaliyo.
  8. UJiao X, Fu MD, Wang YY, Xue J, Zhang Y.Bifidobacterium kunye neLactobacillus yokuthintela i-necrotizing enterocolitis kwiintsana ezinesisindo esiphantsi kakhulu sokuzalwa: uhlolo olucwangcisiweyo kunye nohlalutyo lweemeta. KwiHlabathi J Pediatr. 2020; 16: 135-142. Jonga i-abstract.
  9. I-Sadeghi-Bojd S, Naghshizadian R, Mazaheri M, Ghane Sharbaf F, Assadi F. Ukusebenza kweprobiotic prophylaxis emva kokosuleleka komchamo wokuqala kubantwana abanamaphecana aqhelekileyo okuchama. J Wezifo eziSulelekileyo kwi-Dis Soc. NgoNovemba 2020; 9: 305-310. Jonga i-abstract.
  10. IButler CC, uLau M, uGillespie D, et al. Iziphumo zokusetyenziswa kweprobiotic kulawulo lwe-antibiotic phakathi kwabahlali basekhaya lokhathalelo: Uvavanyo lwezonyango olungenamsebenzi. JAMA. Ngo-2020; 324: 47-56. Jonga i-abstract.
  11. UZhu XL, Tang XG, Qu F, Zheng Y, Zhang WH, uDiao YQ. I-Bifidobacterium inokuxhamla ekuthinteleni i-necrotizing enterocolitis kwiintsana ezizelwe ngaphambi kwexesha: Ukuphononongwa ngokuchanekileyo kunye nokuhlaziywa kwemeta. Int J Uvavanyo. Ngo-2019; 61: 17-25. Jonga i-abstract.
  12. U-Wang G, uFeng D. Unyango olusebenzayo lwe-Saccharomyces boulardii idityaniswe ne-Bifidobacterium kunye nokusebenza kwamaseli omzimba kubantwana abanesifo sorhudo. Ukunyanga ngeMed Med. Ngo-2019; 18: 2653-2659. Jonga i-abstract.
  13. USharif A, uKashani HH, uNasri E, uSoleimani Z, uSharif MR. Indima yeProbiotic kunyango lwedysentery: Uvavanyo lweKlinikhi oluLungelelanisiweyo oluBumbeneyo. Iiproteni zeProbiotic Antimicrob. Ngo-2017; 9: 380-385. Jonga i-abstract.
  14. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Ngaba iiprobiotic zikhuselekile? I-Bifidobacterium bacteremia kumntwana onesifo sentliziyo esomeleleyo. Infez Med. Ngo-2019; 27: 175-178. Jonga i-abstract.
  15. UManzhalii E, Virchenko O, Falalyeyeva T, Beregova T, Stremmel W.Ukusebenza ngokunyanga kokulungiselela iprobiotic ye-steatohepatitis engekho butywala: Ityala lokulingwa. UJ Dig Dis. Ngo-2017; 18: 698-703. Jonga i-abstract.
  16. UKobayashi Y, Kuhara T, Oki M, Xiao JZ. Iziphumo zeBifidobacterium breve A1 ekusebenzeni kwengqondo kubantu abadala abanezikhalazo zememori: ityala elilawulwa ngokungahleliwe, elingaboniyo, elilawulwa yi-placebo. Uncedo lweeMicrobes. Ngo-2019; 10: 511-520. Jonga i-abstract.
  17. UJiang C, uWang H, uXia C, et al. Uvavanyo olulawulwa ngokungekho mthethweni, oluyimfama kabini, olulawulwa yi-placebo lweeprobiotic ukunciphisa ubunzima be-mucositis yomlomo ebangelwa yi-chemoradiotherapy kwizigulana ezine-nasopharyngeal carcinoma. Umhlaza. 2019; 125: 1081-1090. Jonga i-abstract.
  18. Inoue T, Kobayashi Y, Mori N, okqhubekayo. Iziphumo zokudityaniswa kokuhlanganiswa kwe-bifidobacteria kunye noqeqesho lokunganyangeki ekusebenzeni kwengqondo, ukwakheka komzimba kunye nemikhwa yamathumbu ezifundo zabantu abadala abasempilweni. Uncedo lweeMicrobes. 2018; 9: 843-853. Jonga i-abstract.
  19. UDimidi E, uZdanaviciene A, uChristodoulides S, et al. Uvavanyo lwezonyango olungenamsebenzi: I-Bifidobacterium lactis NCC2818 probiotic vs placebo, kunye nefuthe lokuhamba kwamathumbu, iimpawu, kunye ne-gut microbiology ekuqunjelweni okungapheliyo. Ndlela Pharmacol Ther. Ngo-2019; 49: 251-264. Jonga i-abstract.
  20. I-Caglar E. Iziphumo zeBifidobacterium bifidum equlathe iyogathi kwi-plaque yeebhaktiriya zamazinyo ebantwaneni. J Ikliniki yokunyanga abagulayo. Ngo-2014; 38: 329-32. Jonga i-abstract.
  21. UZhang J, Ma S, Wu S, Guo C, Long S, Tan H. Iziphumo zokuNcediswa kweProbiotic kwabafazi abakhulelweyo abanesifo seswekile sesifo seswekile: Uvandlakanyo olucwangcisiweyo kunye noVavanyo lweMeta lweZilingo ezilawulwa ngokungahleliwe. J Isifo seSwekile. Ngo-2019; 2019: 5364730. Jonga i-abstract.
  22. USlykerman RF, uKang J, uVan Zyl N, okqhubekayo. Iziphumo zokuncediswa kwangoko kweprobiotic kulwazi lobuntwana, indlela oziphatha ngayo kunye nomoya ovavanywayo, olawulwa yi-placebo. Acta Paediatr. 2018; 107: 2172-2178. Jonga i-abstract.
  23. Schmidt RM, Pilmann Laursen R, Bruun S, et al. Iiprobiotic kwasebusaneni emva kwexesha zinciphisa imeko ye-eczema: Uvavanyo olulawulwa ngokungenamthetho. Ukunyanga komzimba kwi-Immunol. 2019; 30: 335-340. Jonga i-abstract.
  24. I-Linn YH, Thu KK, iphumelele i-NHH. Iziphumo zeProbiotic yoThintelo lweRadiation eQhelekileyo-Isifo sohudo phakathi kwabaguli abanomhlaza womlomo wesibeleko: isifundo esilawulwa ngokungaqhelekanga sePlacebo. Iiproteni zeProbiotic Antimicrob. 2019; 11: 638-647. Jonga i-abstract.
  25. UCallaway LK, uMcIntyre HD, uBarrett HL, et al. Iiprobiotiki zoThintelo lweSifo seSifo seSwekile esiGestational kuMfazi oTyebileyo kunye nabaTyebileyo: Iziphumo ezifunyenwe kwi-SPRING Double-Blind Randomised Trial. Unonophelo lweSwekile. 2019; 42: 364-371. Jonga i-abstract.
  26. Staudacher HM, Lomer MCE, Farquharson FM, okqhubekayo. Ukutya okunezinga eliphantsi kwii-FODMAPs kunciphisa iiMpawu kwizigulana ezine-Irritable Bowel Syndrome kunye neProbiotic ebuyisela iintlobo zeBifidobacterium: Ityala elilawulwa ngokungahleliwe. Gastroenterology. Ngo-2017; 153: 936-947. Jonga i-abstract.
  27. UMatsuoka K, Uemura Y, uKaii T, et al. Ukusebenza kweBifidobacterium breve Milk Milmented in Conservation of Remission of Ulcerative Colitis. Ukumba iDisci. Ngo-2018; 63: 1910-1919. Jonga i-abstract.
  28. U-Liu J, u-Huang XE. Ukusebenza kweBifidobacterium tetragenous iipilisi zebhakteriya ezinokubakho kwizigulana ezinomhlaza ezinesibindi sokuqhinwa. I-Asia Pac J Umhlaza ngaphambili. Ngo-2014; 15: 10241-4. Jonga i-abstract.
  29. Lau AS, Yanagisawa N, Hor YY, et al. I-Bifidobacterium longum i-BB536 inciphise izifo eziphezulu zokuphefumla kunye neeprofayili ze-microbiota eziguqulweyo kubantwana baseMalay pre-school. Uncedo lweeMicrobes. 2018; 9: 61-70. Jonga i-abstract.
  30. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Iziphumo zeentsuku ezingama-28 zeBifidobacterium animalis subsp. Isongezelelo se-lactis HN019 ngexesha lokuhamba kwe-colonic kunye neempawu zesisu kubantu abadala abanokuqunjelwa okusebenzayo: Uvavanyo oluyimfama kabini, olungenamkhethe, olulawulwa yi-placebo, kunye nolwahlulo lwethamo. Imichiza yesibindi. 2018; 9: 236-251. Jonga i-abstract.
  31. U-Guardamagna O, uAmaretti A, uPuddu PE, et al. Ukuxhaswa kweBifidobacteria: Iziphumo kwiiprofayili zeplasma lipid kubantwana abanesifo se-dyslipidemic. Isondlo. Ngo-2014; 30 (7-8): 831-6. Jonga i-abstract.
  32. UBadehnoosh B, uKaramali M, uZarrati M, et al. Iziphumo zokongezwa kweprobiotic kwii-biomarkers zokukrala, uxinzelelo lwe-oxidative kunye neziphumo zokukhulelwa kwisifo seswekile sokukhulelwa. J Umama okhulayo umntwana osandul 'ukuzalwa. Ngo-2018 ngoMeyi; 31: 1128-1136. Jonga i-abstract.
  33. UDickerson F, uAdamos M, uKatsafanas E, et al. Unyango lwe-probiotic yecandelo lokudibanisa ukuthintela ukwenziwa kwakhona kwizigulana ezine-mania ebukhali: Uvavanyo olulawulwa ngokungenamthetho. Ukuphazamiseka kwiBipolar. 2018 ngoMatshi 25. Jonga into engabonakaliyo.
  34. I-Pinto GS, i-Cenci MS, i-Azevedo MS, i-Epifanio M, uJones MH. Iziphumo zeyogathi eneBifidobacterium animalis subsp. I-lactis DN-173010 probiotic kwi-plaque yamazinyo kunye namathe kwizigulana ze-orthodontic. Caries Res. Ngo-2014; 48: 63-8. Jonga i-abstract.
  35. UZamani B, uGolkar HR, uFarshbaf S, et al. Impendulo yeklinikhi kunye ne-metabolic kwi-supplementation ye-probiotic kwizigulane ezine-rheumatoid arthritis: i-randomised, blind-blind, trialbo-controlled trial. I-Int J Rheum Dis 2016; 19: 869-79. Jonga i-abstract.
  36. IPinto-Sanchez MI, i-GB yeHolo, iGhajar K, et al. Iprobiotic Bifidobacterium longum NCC3001 inciphisa amanqaku oxinzelelo kunye nokutshintsha umsebenzi wengqondo: isifundo somqhubi kwizigulana ezinesifo samathumbu. I-Gastroenterology 2017; 153: 448-459.e8. Jonga i-abstract.
  37. UKaramali M, uDadkhah F, uSadrkhanlou M, et al. Iziphumo zokongezwa kweprobiotic kulawulo lwe-glycemic kunye neeprofayili zesifo seswekile: ukulawulwa okungafunekiyo, okungaboniyo, okulawulwa yi-placebo. Isifo seswekile iMetab 2016; 42: 234-41. Jonga i-abstract.
  38. UJäger R, uPurura M, uLitye JD, et al. Iprobiotic iStreptococcus thermophilus FP4 kunye neBifidobacterium breve BR03 isongezelelo sithintela ukusebenza kunye noluhlu lwezinto ezihamba-hambayo emva kokuzilolonga kwemisipha. Izondlo 2016; 8. IPH: E642. Jonga i-abstract.
  39. UWorwell PJ, uAltringer L, uMorel J, et al. Ukusebenza kwe-probiotic ebhaliweyo ye-Bifidobacterium infantis 35624 kwabasetyhini abanesifo samathumbu esinganyanzelekanga. NdinguJ Gastroenterol. NgoJulayi 2006; 101: 1581-90. Jonga i-abstract.
  40. ILau CS, iChamberlain RS. Iiprobiotic ziyasebenza ekuthinteleni isifo sohudo esihambelana neClostridium difficile: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta. Int J Gen iMed. Ngo-2016; 9: 27-37. Jonga i-abstract.
  41. UStenman LK, uLehtinen MJ, uMeland N, et al. Probiotic kunye okanye ngaphandle kweFayibha yokuLawula amaFutha eMisa, ehambelana ne-Serum Zonulin, kuTyebo lokuTyeba kakhulu kunye nokuTyeba kwabantu abadala. I-EBioMedicine 2016; 13: 190-200. Jonga i-abstract.
  42. USato S, Uchida T, Kuwana S, okqhubekayo. I-Bacteremia ebangelwa yi-Bifidobacterium breve kusana olusandul 'ukuzalwa kunye ne-cloacal exstrophy. Nyana Int. Ngo-2016; 58: 1226-8. Jonga i-abstract.
  43. UJayasimhan S, Yap NY, Roest Y, Rajandram R, Chin KF. Ukusebenza kwamalungiselelo eeseli ezincinci ekuphuculeni ukuqhina okungapheliyo: ityala elilawulwa ngokungahleliwe, elingaboniyo, elilawulwa yi-placebo. Iiklinikhi zeNutr 2013; 32: 928-34. Jonga i-abstract.
  44. UHan K, uWang J, u-Seo JG, uKim H. Ukusebenza kweeprobiotiki eziboshwe kabini kwisifo sengqondo samathumbu: isilingo esilawulwa ngokungapheliyo. J Gastroenterol. Ngo-2017; 52: 432-443. Jonga i-abstract.
  45. I-Chang HY, i-Chen JH, i-Chang JH, i-Lin HC, i-Lin CY, i-Peng CC. Iindidi ezininzi zeeprobiotiki zibonakala njengeyona ndlela isebenzayo kuthintelo lwe-necrotizing enterocolitis kunye nokufa: Uhlalutyo lweemeta oluhlaziyiweyo. Inye. Ngo-2017; 12: e0171579. Jonga i-abstract.
  46. I-Bastürk A, u-Artan R, u-Yilmaz A. Ukusebenza kwe-synbiotic, iprobiotic, kunye nonyango lwe-prebiotic yesifo sengqondo samathumbu ebantwaneni: Uvavanyo olulawulwa ngokungakhethiyo. I-Turk J Gastroenterol 2016; 27: 439-43. Jonga i-abstract.
  47. I-Blaabjerg S, i-Artzi DM, i-Aabenhus R. Iiprobiotic zoThintelo lwe-Antibiotic-Associated Diarrhea kwizigulana ezingaphandle-Uvavanyo oluCwangcisiweyo kunye neMeta-Uhlalutyo. Amayeza okubulala iintsholongwane (iBasel). Ngo-2017; 6. Jonga i-abstract.
  48. IAl Faleh K, Anabrees J.Iiprobiotiki zokuthintela ukungena kwi-neocolotitis kwiintsana ezizelwe ngaphambi kwexesha. Isiseko sedatha yeCochrane Isityhi sika-2014; CD005496. Jonga i-abstract.
  49. UDimidi E, uChristodoulides S, uFragkos KC, uScott SM, uWhelan K. Iziphumo zeeprobiotic ekusebenzeni kwesisu kubantu abadala: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta zezilingo ezilawulwa ngokungahleliwe. NdinguJ oNyango lweeKlinikhi. Ngo-2014; 100: 1075-84. Jonga i-abstract.
  50. I-Wildt S, i-Nordgaard I, i-Hansen U, i-Brockmann E, i-Rumessen JJ. Uvavanyo olulawulwa ngokungaqhelekanga lwe-placebo olulawulwa yi-Lactobacillus acidophilus La-5 kunye neBifidobacterium animalis subsp. I-lactis BB-12 yolondolozo lokuxolelwa kwi-ulcerative colitis. J Crohns Colitis 2011; 5: 115-21. Jonga i-abstract.
  51. UShen J, uZuo ZX, Mao AP. Iziphumo zeprobiotic ekunciphiseni ukuxolelwa kunye nokugcina unyango kwi-ulcerative colitis, isifo sikaCrohn, kunye nepouchitis: uhlalutyo lweemeta zezilingo ezilawulwa ngokungahleliwe. Ukudumba kwesisu Dis. Ngo-2014; 20: 21-35. Jonga i-abstract.
  52. Ipaki MS, Kwon B, Ku S, Ji GE4. Ukusebenza kweBifidobacterium longum BORI kunye neLactobacillus acidophilus AD031 Unyango lweProbiotic kwiintsana ezineSifo seRotavirus. Izondlo. Ngo-2017; 9. IPH: E887. Jonga i-abstract.
  53. I-Søndergaard B, i-Olsson J, i-Ohlson K, i-Svensson U, i-Bytzer P, i-Ekesbo R.Iziphumo zobisi lweprobiotic olubilisiweyo kwiimpawu kunye neentyatyambo zamathumbu kwizigulana ezinesifo samathumbu: IScand J Gastroenterol 2011; 46: 663-72. Jonga i-abstract.
  54. USimrén M, u-Ohman L, u-Olsson J, et al. Ulingo lwezonyango: Iziphumo zobisi olunamafutha avelisiweyo aneebhaktiriya ezintathu zeprobiotic kwizigulana ezinesifo samathumbu esinganyanzelekanga- isifundo esilawulwa ngokungahleliwe, esingaboniyo, esilawulwayo. Ukudibana kweFarmacol Ther 2010; 31: 218-27. Jonga i-abstract.
  55. IGoldenberg JZ, uLytvyn L, uSteurich J, uParkin P, uMahant S, uJohnston BC. Iiprobiotic zokuthintela isifo sorhudo esihambelana nabantwana. Isiseko sedatha yeCochrane Isityhi 2015; CD004827. Jonga i-abstract.
  56. O'Callaghan A, van Sinderen D. Bifidobacteria kunye neNdima yabo njengamalungu oLuntu iGut Microbiota. Microbiol yangaphambili. Ngo-2016 uJuni 15; 7: 925. Jonga i-abstract.
  57. UOlivares M, uCastillejo G, uVarea V, uSanz Y.Uvavanyo lokungenelela olulawulwa kabini ngokungaboniyo, olungenamkhethe, lokuvavanya iziphumo ze-Bifidobacterium longum CECT 7347 kubantwana abanesifo se-celiac esisandula ukufunyanwa. Br J Isondlo. Ngo-2014 ngoJulayi 14; 112: 30-40. Jonga i-abstract.
  58. IHojsak I, iTokic Pivac V, iMocic Pavic A, iPasini AM, iKolacek S.Bifidobacterium animalis subsp. I-lactis iyasilela ukuthintela usulelo oluqhelekileyo kubantwana abasesibhedlele: isifundo esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo. NdinguJ oNyango lweeKlinikhi. Ngo-2015 Mar; 101: 680-4. Jonga i-abstract.
  59. U-Eskesen D, uJespersen L, uMichelsen B, uWorwell PJ, uMüller-Lissner S, uMorberg CM. Iziphumo zohlobo lweprobiotic Bifidobacterium animalis subsp. I-lactis, i-BB-12®, yokuya rhoqo kwizifundo ezisempilweni ezinesantya esiphantsi sokuzithuma kunye nokungonwabi esiswini: ukulawulwa okungafunekiyo, okungaboni kabini, ukulawulwa kwe-placebo, ukulingwa kweqela elifanayo. Br J Isondlo. Ngo-2015 uNov 28; 114: 1638-46. Jonga i-abstract.
  60. ICosteloe K, Hardy P, Juszczak E, Wilks M, Millar MR; Iiprobiotiki kwiQela lokuDibana leentsana eziQalayo. I-Bifidobacterium breve BBG-001 kwiintsana ezizelwe ngaphambi kwexesha: ulingo olulawulwa ngononophelo lwesigaba 3. ILancet. Ngo-2016 ngoFebruwari 13; 387: 649-60. Jonga i-abstract.
  61. UAllen SJ, uWareham K, uWang D, uBradley C, uHutchings H, uHarris W, uDhar A, uBrown H, uFoden A, uGravenor MB, uMack D. I-Lactobacilli kunye ne-bifidobacteria kuthintelo lohudo olunxulumene ne-antibiotic kunye neClostridium difficile urhudo kubantu abadala Izigulana ezingalaliswayo (i-PLACIDE): ilingo elingahleliwe, elilawulwa kabini, elilawulwa yi-placebo, ulingo oluninzi. ILancet. Ngo-2013 ngo-Oktobha 12; 382: 1249-57. Jonga i-abstract.
  62. Roberfroid MB. Ii-prebiotic kunye neprobiotic: ngaba kukutya okusebenzayo? NdinguJ oNyango lweeKlinikhi. 2000; 71 (6 Suppl): 1682S-7S; ingxoxo 1688S-90S. Jonga i-abstract.
  63. I-Wang YH, i-Huang Y.Impembelelo yeLactobacillus acidophilus kunye ne-Bifidobacterium bifidum yokuncedisa kunyango olusemgangathweni kathathu kwi-Helicobacter pylori yokupheliswa kunye notshintsho olunamandla kwi-flora yamathumbu. Kwihlabathi J Microbiol Biotechnol. Ngo-2014; 30: 847-53. Jonga i-abstract.
  64. UWang ZH, uGao QY, uFang JY. Uhlalutyo lwe-Meta lokusebenza kunye nokhuseleko lwe-Lactobacillus equlathe kunye ne-Bifidobacterium ene-probiotic yokulungiselela ikhompawundi kwi-Helicobacter pylori yonyango yokuphelisa. J Klinikhi yeGastroenterol. Ngo-2013; 47: 25-32. Jonga i-abstract.
  65. IVidelock EJ, iCremonini F. Uhlalutyo lweMeta: Iiprobiotiki kuhudo olunxulunyaniswa namayeza. Ndlela Pharmacol Ther. Ngo-2012; 35: 1355-69. Jonga i-abstract.
  66. UTomasz B, Zoran S, Jaroslaw W, Ryszard M, Marcin G, Robert B, Piotr K, Lukasz K, Jacek P, Piotr G, Przemyslaw P, Michal D. Ukusetyenziswa kwexesha elide kweprobiotic Lactobacillus kunye neBifidobacterium kunefuthe lokuthintela ukwenzeka kunye nobukrakra bepouchitis: isifundo esinokwenzeka ngokungahleliwe. Ucocekile kwi-Int Int. Ngo-2014; 2014: 208064. Jonga i-abstract.
  67. UShavakhi A, Tabesh E, Yaghoutkar A, Hashemi H, Tabesh F, Khodadoostan M, Minakari M, Shavakhi S, Gholamrezaei A. Iziphumo ze-multistrain probiotic compound kwi-bismuth equkethe unyango olunamacala amane osulelo lwe-Helicobacter pylori usulelo: -ukufunda okungaboniyo. Helicobacter. Ngo-2013; 18: 280-4. Jonga i-abstract.
  68. IRerksuppaphol S, iRerksuppaphol L. Uvavanyo olulawulwa ngokungahleliwe lweeprobiotiki ukunciphisa ukubanda okuqhelekileyo kubantwana besikolo. Nyana Int. Ngo-2012; 54: 682-7. Jonga i-abstract.
  69. URautava S, uKainonen E, uSalminen S, uIsolauri E.Ukuxhaswa kweprobiotic koomama ngexesha lokukhulelwa kunye nokuncancisa kunciphisa umngcipheko we-eczema kusana. J Iklinikhi yokunyanga i-Immunol. Ngo-2012; 130: 1355-60. Jonga i-abstract.
  70. Langkamp-Henken B, Rowe CC, Ford AL, Christman MC, Nieves C Jr, Khouri L, Specht GJ, Girard SA, Spaiser SJ, Dahl WJ. I-Bifidobacterium bifidum R0071 ikhokelela kwinani elikhulu leentsuku ezisempilweni kunye neepesenti esezantsi zabafundi abaxinzelelekileyo kwizifundo abanika ingxelo ngemini yengqele / yomkhuhlane: isifundo esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo. Br J Isondlo. Ngo-2015 14; 113: 426-34. Jonga i-abstract.
  71. Gore C, Custovic A, Tannock GW, Munro K, Kerry G, Johnson K, Peterson C, Morris J, Chaloner C, Murray CS, Woodcock A. Unyango kunye neziphumo zothintelo lwesibini lweprobiotic Lactobacillus paracasei okanye iBifidobacterium lactis kwi-eczema yabantwana Uvavanyo olulawulwa ngokungenamthetho kunye nokulandela de kube li-3 iminyaka. Iiklinikhi ze-Explergy 2012; 42: 112-22. Jonga i-abstract.
  72. IFernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, Gallardo-Sarmiento RB, García-Pérez CS, Montaño-Rodríguez R, Echániz-Aviles MO. Imfama kabini, iimvavanyo zeklinikhi zokuvavanya ukusebenza kakuhle kweeprobiotiki kwiintsana ezisandula ukuzalwa ezinobunzima obungaphantsi kwe-1500 g kuthintelo lwe-necrotising enterocolitis. IArch Dis Umntwana osandul 'ukuzalwa Ed 2013; 98: F5-9. Jonga i-abstract.
  73. Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Unyango lwexesha elide kunye neeprobiotic kwizigulana zononophelo lokuqala ezinezilonda ezinganyangekiyo zesilonda- isilingo esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo. IScand J Gastroenterol 2013; 48: 1127-35. Jonga i-abstract.
  74. Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor MB, Garaiova I, Plummer SF, Wang D, Morgan G. Probiotic kuthintelo lwe-eczema: ityala elilawulwa ngokungahleliwe. IArch Dis yabantwana ngo-2014; 99: 1014-9. Jonga i-abstract.
  75. Das RR Singh M, Shafiq N. Probiotic kunyango lweAllergic Rhinitis. Ijenali yoLwabiwo lweHlabathi yeHlabathi ngo-2010; 3: 239-244.
  76. Seki M, Igarashi T Fukuda Y Simamura S Kaswashima T Ogasa K. Iziphumo zeBifidobacterium yobisi olukhulisiweyo "rhoqo" phakathi kweqela elidala. Ukutya okunesondlo 1978; 31: 379-387.
  77. I-Kageyama T, i-Nakano Y Tomoda T. yokuThelekisa iSifundo kuLawulo lwe-Oral yoLungiselelo oluthile lweBifidobacterium. Amayeza kunye neBiology (eJapan) 1987; 115: 65-68.
  78. I-Kageyama T, Tomoda T Nakano Y. Iziphumo zoLawulo lweBifidobacterium kwizigulana ezineleukemia. IBifidobacteria Microflora. Ngo-1984; 3: 29-33.
  79. I-Ballongue J, i-Grill J Baratte-Euloge P. Intshukumo ye la flore intestinale de laits fermentés okanye iBifidobacterium. Ukuqala ngo-1993; 73: 249-256.
  80. Ogata T, Kingaku M Yaeshima T Teraguchi S Fukuwatari Y Ishibashi N Hayasawa H Fujisawa T Lino H. Iziphumo zeBifidobacterium longum BB536 yolawulo lweyogathi kwindawo yamathumbu yabantu abadala abasempilweni. IMicrob Ecol yezeMpilo kwi-Dis 1999; 11: 41-46.
  81. I-Tomoda T, Nakano Y Kageyama T. Umahluko kumaQela amaNcinci eeFlatest Intestinal Flora ngexesha loLawulo lweAnticancer okanye iziyobisi ze-Immunosuppressive. Amayeza kunye neBiology (eJapan) 1981; 103: 45-49.
  82. UTomoda T, Nakano Y Kageyama T. Ukwanda kwamathumbu eCandida kunye nosulelo lweCandida kwizigulana ezineleukemia: Iziphumo zoLawulo lweBifidobacterium. IBifidobacteria Microflora 1988; 7: 71-74.
  83. Araya-Kojima Tomoko, Yaeshima Tomoko Ishibashi Norio Shimamura Seiichi Hayasawa Hirotoshi. Iziphumo zokuthintela i-Bifidobacterium longum BB536 kwi-Bacteria ye-Intestinal Intestinal. IBifidobacteria Microflora 1995; 14: 59-66.
  84. UNamba K, Yaeshima T Ishibashi N Hayasawa H kunye no Yamazaki Shoji. Iziphumo zokuthintela i-Bifidobacterium longum kwi-Enterohemorrhagic Escherichia coli O157: H7. I-Bioscience Microflora 2003; 22: 85-91.
  85. Igarashi M, Iiyama Y Kato R Tomita M Asami N Ezawa I. Iziphumo zeBifidobacterium longum kunye ne-lactulose kumandla ethambo kwi-ovariectomized osteoporosis rates rates. IBifidus 1994; 7: 139-147.
  86. Yaeshima T, Takahashi S Ota S Nakagawa K Ishibashi N Hiramatsu A Ohashi T Hayasawa H Iino H. Iziphumo zeyogathi emnandi equkethe i-Bifidobacterium longum BB536 kumjikelo wokuya kwinqanaba kunye neempawu zokungcola zabantu abadala abasempilweni: Thelekisa i-yogurt esemgangathweni esemgangathweni. UKenko Eiyo Shokuhin Kenkyu 1998; 1 (3/4): 29-34.
  87. Yaeshima T, Takahashi S Matsumoto N Ishibashi N Hayasawa H Lino H. Iziphumo zeyogathi equlethe iBifidobacterium longum BB536 kwimeko yamathumbu, iimpawu zelindle kunye nokuhamba rhoqo: Ukuthelekiswa neyogathi esemgangathweni. I-Biosci Microflora 1997; 16: 73-77.
  88. I-Xiao J, Kondol S Odamaki T Miyaji K Yaeshima T Iwatsuki K Togashi H Benno Y. Iziphumo zeyogathi eziqukethe iBifidobacterium longum BB 536 kwisimo sokuya rhoqo kunye neempawu zokungcola kwabantu abadala abasempilweni: Ukuwela umnqamlezo ongaboniyo kabini. Ijenali yaseJapan yeLactic Acid Bacteria 2007; 18: 31-36.
  89. Yaeshima T, Takahashi S Ogura A Konno T Iwatsuki K Ishibashi N Hayasawa H. Iziphumo zobisi olungavundiswanga oluqukethe i-Bifidobacterium longum BB536 kwi-Defecation Frequency kunye ne-Fecal Characteristics kubantu abadala abasempilweni. Ijenali yokutya kwesondlo 2001; 4: 1-6.
  90. I-Ogata T, Nakamura T Anjitsu K Yaeshima T Takahashi S Fukuwatari Y Ishibashi N Hayasawa H Fujisawa T Iino H. Iziphumo zeBifidobacterium longum BB536 kulawulo lwendawo yamathumbu, ubungakanani bentshukumo kunye neempawu zokungcola kwamavolontiya abantu. I-Biosci Microflora 1997; 16: 53-58.
  91. Iwabuchi N, Hiruta N Kanetada S Yaeshima T Iwatsuki K Yasui H. Iziphumo zoLawulo lwe-Intranasal ye-Bifidobacterium longum BB536 kwi-Mucosal Immune System kwi-Respiratory Tract and Influenza Virus Infection kwiimpuku. Inzululwazi yobisi 2009; 38: 129-133.
  92. I-Sekine I, Yoshiwara S Homma N Takanori H Tonosuka S. Iziphumo zobisi lwe-Bifidobacterium ene-milk kwi-chemiluminescence reaction of peripheral leukocytes kwaye zithetha umthamo weeseli ezibomvu zegazi-indima enokwenzeka yeBifidobacterium ekusebenziseni ii-macrophages. Unyango (eJapan) 1985; 14: 691-695.
  93. U-Singh, J., Rivenson, A., Tomita, M., Shimamura, S., Ishibashi, N., kunye no-Reddy, BS Bifidobacterium longum, i-lactic acid evelisa ibacteria yamathumbu evimbela umhlaza wekolon kwaye imodareyitha izinto eziphakathi ze-colon carcinogenesis . ICarcinogenesis 1997; 18: 833-841. Jonga i-abstract.
  94. UReddy, B. S. noRivenson, A. Isithintelo sesiphumo seBifidobacterium longum kwikholoni, mammary, nakwisibindi se-carcinogenesis ebangelwa yi-2-amino-3-methylimidazo [4,5-f] quinoline, ukutya mutagen. Umhlaza Res. 9-1-1993; 53: 3914-3918. Jonga i-abstract.
  95. Yamazaki, S., Machii, K., Tsuyuki, S., Momose, H., Kawashima, T., kunye no-Ueda, K. Iimpendulo ze-immune kwi-BonoBumidi ye-Bifidobacterium longum kunye nolwalamano lwabo nokukhusela ukuhlasela kwebhaktheriya. Utyando 1985; 56: 43-50. Jonga i-abstract.
  96. UKondo, J., Xiao, J. Z., Shirahata, A., Baba, M., Abe, A., Ogawa, K., kunye noShimoda, T. Iziphumo zokumodareyitha kweBifidobacterium longum BB536 ekuchaseni kwizigulana esele zikhulile ezifumana ukutya kwangaphakathi. Ihlabathi J Gastroenterol 4-14-2013; 19: 2162-2170. Jonga i-abstract.
  97. Akatsu, H., Iwabuchi, N., Xiao, JZ, Matsuyama, Z., Kurihara, R., Okuda, K., Yamamoto, T., kunye noMaruyama, M. Iziphumo zeklinikhi zeProbiotic Bifidobacterium longum BB536 kwi-Immune Function kunye Intrinal Intrinal Microbiota kwiZigulana eziDala eziFumana ukuTya kweTyhubhu kwangaphakathi. I-JPEN J Umzali oNgena ngaphakathi kwiNutriti 11-27-2012; Jonga i-abstract.
  98. Odamaki, T., Sugahara, H., Yonezawa, S., Yaeshima, T., Iwatsuki, K., Tanabe, S., Tominaga, T., Togashi, H., Benno, Y., kunye noXiao, JZ Isiphumo yokutya ngomlomo iyogathi equlathe iBifidobacterium longum BB536 kumanani eseli e-enterotoxigenic Bacteroides fragilis kwi microbiota. Anaerobe. Ngo-2012; 18: 14-18. Jonga i-abstract.
  99. Iwabuchi, N., Xiao, J. Z., Yaeshima, T., kunye no-Iwatsuki, K. Ulawulo lomlomo lweBifidobacterium longum lonyusa usulelo lwegciwane lesifo somkhuhlane kwiimpuku. Biol.Umveliso.Inkunzi yenkomo. Ngo-2011; 34: 1352-1355. Jonga i-abstract.
  100. Simakachorn, N., Bibiloni, R., Yimyaem, P., Tongpenyai, Y., Varavithaya, W., Grathwohl, D., Reuteler, G., Maire, JC, Blum, S., Steenhout, P., Benyacoub. , J., kunye neSchiffrin, i-EJ Ukunyamezelana, ukhuseleko, kunye nefuthe kwi-faecal microbiota yefomula yokungenisa yongezwa nge-pre-kunye neprobiotic kubantwana abagula kakhulu. J Isidlangalala. Gastroenterol. Ngo-2011; 53: 174-181. Jonga i-abstract.
  101. Hascoet, J. M., Hubert, C., Rochat, F., Legagneur, H., Gaga, S., Emady-Azar, S., kunye noSeenhout, P. G. Iziphumo zokwenziwa kwefomula kuphuhliso lwe-gut gut ye-microbiota. J Isidlangalala. Gastroenterol. Ngo-2011; 52: 756-762. Jonga i-abstract.
  102. UFirmansyah, A., Dwipoerwantoro, P.G, Kadim, M., Alatas, S., Conus, N., Lestarina, L., Bouisset, F., kunye noSteenhout, P. Ukukhula okuphuculweyo kwabantwana abancinci batyisa ubisi oluqukethe i-synbiotic. I-Asia Pac. J Iklinikhi. Ngo-2011; 20: 69-76. Jonga i-abstract.
  103. I-Tang, M. L., Lahtinen, S. J., kunye noBoyle, R. J. Iiprobiotic kunye ne-prebiotic: iziphumo zeklinikhi kwizifo ezichasayo. I-Curr.Opin.Izilwanyana. Ngo-2010; 22: 626-634. Jonga i-abstract.
  104. UNamba, K., Hatano, M., Yaeshima, T., Takase, M., kunye no-Suzuki, K. Iziphumo ze-Bifidobacterium longum BB536 kulawulo losulelo lwe-influenza, i-influenza vaccine antibody titer, kunye nokuzikhusela kwiseli kubantu abadala. Biosci. Biotechnol. Ibhayiloji. Ngo-2010; 74: 939-945. Jonga i-abstract.
  105. UGianotti, L., Morelli, L., Galbiati, F., Rocchetti, S., Coppola, S., Beneduce, A., Gilardini, C., Zonenschain, D., Nespoli, A., kunye noBraga, M. Uvavanyo olungahleliwe lokungaboni kakuhle kulawulo lwentsebenzo yeeprobiotiki kwizigulana ezinomhlaza. Kwihlabathi J Gastroenterol. 1-14-2010; 16: 167-175. Jonga i-abstract.
  106. I-Andrade, S. kunye ne-Borges, N. Iziphumo zobisi olunamafutha aqukethe iLactobacillus acidophilus kunye neBifidobacterium longum kwiiplasma lipids yabasetyhini abane-cholesterol eqhelekileyo okanye emiselweyo. J. Indawo yobisi. Ngo-2009; 76: 469-474. Jonga i-abstract.
  107. URouge, C., iPiloquet, H., Butel, MJ, Berger, B., Rochat, F., Ferraris, L., Des, Robert C., Legrand, A., de la Cochetiere, MF, N'Guyen, I-JM, iVodovar, M., Voyer, M., iDarmaun, D., kunye neRozze, i-JC yokunikezelwa ngomlomo kunye neeprobiotiki kwiintsana ezinesisindo esiphantsi kakhulu sokuzalwa: ubunzima obungenamkhethe, obunemfama kabini, olulawulwa yi-placebo. Ndingu. J Kliniki. Ngo-2009; 89: 1828-1835. Jonga i-abstract.
  108. Iwabuchi, N., Takahashi, N., Xiao, JZ, Yonezawa, S., Yaeshima, T., Iwatsuki, K., kunye noHachimura, S. Iziphumo zokucinezela zeBifidobacterium longum kwimveliso ye-Th2-etsala iichemokines ezibangelwa yi-T ukusebenzisana kweseli-antigen-ebonisa ukusebenzisana kweseli. I-FEMS Immunol, kunye neMicrobiol. Ngo-2009; 55: 324-334. Jonga i-abstract.
  109. Takeda, Y., Nakase, H., Namba, K., Inoue, S., Ueno, S., Uza, N., kunye noChiba, T.Ukulawulwa kweT-ukubheja kunye neemolekyuli ezixineneyo zokudibanisa yiBifidobactrium longum iphucula ukudumba kwe-colonic. yokudumba okwenziwa sisilonda sikabhobhosi. Ukuvuvukala. Ngo-2009; 15: 1617-1618. Jonga i-abstract.
  110. Soh, SE, Aw, M., Gerez, I., Chong, YS, Rauff, M., Ng, YP, Wong, HB, Pai, N., Lee, BW, kunye neShek, LP Probiotic supplementation kwi-6 yokuqala Iinyanga zobomi ezisengozini kwiintsana zaseAsia- iimpembelelo kwi-eczema kunye nokukhuthaza u-atopic kwiminyaka eyi-1. Iiklinikhi.Ukunyanga ngo-2009; 39: 571-578. Jonga i-abstract.
  111. Odamaki, T., Xiao, JZ, Sakamoto, M., Kondo, S., Yaeshima, T., Iwatsuki, K., Togashi, H., Enomoto, T., noBenno, Y. Ukusasazwa kweentlobo ezahlukeneyo ze Iqela leBacteroides fragilis kubantu abaneJapan cedar pollinosis. Appl.Environ.Imicrobiol. Ngo-2008; 74: 6814-6817. Jonga i-abstract.
  112. del Giudice, M. M. and Brunese, F. P. Probiotic, prebiotic, and allergy ebantwaneni: yintoni entsha kunyaka ophelileyo? J Klinikhi yeGastroenterol. 2008; 42 iSuppl 3 Pt 2: S205-S208. Jonga i-abstract.
  113. Chouraqui, JP, Grathwohl, D., Labaune, JM, Hascoet, JM, de, Montgolfier, mna, Leclaire, M., Giarre, M., kunye noSeenhout, P. Uvavanyo lokhuseleko, unyamezelo, kunye nefuthe lokhuselo ngokuchasene norhudo. Iifomula zeentsana ezinemixube yeeprobiotiki okanye iiprobiotic kunye nee-prebiotic kwityala elilawulwa ngokungahleliwe. Ndingu. J Kliniki. Ngo-2008; 87: 1365-1373. Jonga i-abstract.
  114. Matsumoto, T., Ishikawa, H., Tateda, K., Yaeshima, T., Ishibashi, N., kunye no-Yamaguchi, K. Ulawulo lomlomo lwe-Bifidobacterium longum kuthintela i-Pseudomonas aeruginosa sepsis efumaneka emathunjini kwiimpuku. J Appl, iMicrobiol. Ngo-2008; 104: 672-680. Jonga i-abstract.
  115. Odamaki, T., Xiao, JZ, Iwabuchi, N., Sakamoto, M., Takahashi, N., Kondo, S., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, T., kunye I-Benno, Y. Impembelelo ye-Bifidobacterium longum BB536 ifumana i-faecal microbiota kubantu abane-cedar pollinosis yaseJapan ngexesha lexesha le-pollen. J Med, iMicrobiol. 2007; 56 (Pt 10): 1301-1308. Jonga i-abstract.
  116. Iwabuchi, N., Takahashi, N., Xiao, J. Z., Miyaji, K., kunye no-Iwatsuki, K. In vitro Th1 cytokine-Independent Th2 effects suppression of bifidobacteria. Intsholongwane. Ngo-2007; 51: 649-660. Jonga i-abstract.
  117. IXiao, JZ, Kondo, S., Takahashi, N., Odamaki, T., Iwabuchi, N., Miyaji, K., Iwatsuki, K., kunye ne-Enomoto, T. Utshintsho kumanqanaba e-plasma TARC ngexesha le-pollen yaseJapan kunye ubudlelwane kunye nophuhliso lweempawu. Int.Arch.Ukuhlaselwa komzimba. Ngo-2007; 144: 123-127. Jonga i-abstract.
  118. Odamaki, T., Xiao, JZ, Iwabuchi, N., Sakamoto, M., Takahashi, N., Kondo, S., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, T., kunye Ukutshintsha kwe-fecal microbiota kubantu abane-cedar pollinosis yaseJapan ngexesha lexesha le-pollen kunye nefuthe lokudalwa kweprobiotic. J Uphando. Allergol. Clin. Immunol. Ngo-2007; 17: 92-100. Jonga i-abstract.
  119. I-Xiao, JZ, Kondo, S., Yanagisawa, N., Miyaji, K., Enomoto, K., Sakoda, T., Iwatsuki, K., kunye ne-Enomoto, T. Ukusebenza kweklinikhi kweprobiotic Bifidobacterium longum kunyango lweempawu IJapan impova yomsedare yokungezwani komzimba kwizifundo ezivavanywe kwiyunithi yokuvezwa kwendalo. Allergol.Int. Ngo-2007; 56: 67-75. Jonga i-abstract.
  120. UPuccio, G., Cajozzo, C., Meli, F., Rochat, F., Grathwohl, D., noSteenhout, P. Uvavanyo lwezonyango lwendlela entsha yokuqalisa yeentsana eziqukethe i-Bifidobacterium longum BL999 kunye ne-prebiotic. Isondlo 2007; 23: 1-8. Jonga i-abstract.
  121. Xiao, JZ, Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, K., kunye I-Enomoto, T. Iiprobiotiki kunyango lwe-cedar pollinosis yaseJapan: ityala elilawulwa kabini elingaboniyo. Iiklinikhi. Ukunyanga ngo-2006; 36: 1425-1435. Jonga i-abstract.
  122. Xiao, JZ, Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, K., kunye I-Enomoto, T. Iziphumo zeprobiotic Bifidobacterium longum BB536 [ilungisiwe] ekupheliseni iimpawu zeklinikhi kunye nokuguqula amanqanaba e-cytokine yeplasma ye-cedar pollinosis yaseJapan ngexesha lexesha le-pollen. Uvavanyo olulawulwa ngokungaqhelekanga, olulawulwa yi-placebo. J Uphando. Allergol. Clin. Immunol. Ngo-2006; 16: 86-93. Jonga i-abstract.
  123. UBennet, R., Nord, C. E., kunye noZetterstrom, R. Ukudluliswa kwamathambo okwethutyana kweentsana ezisanda kuzalwa nge-bifidobacteria yomlomo kunye ne-lactobacilli. Acta Paediatr. Ngo-1992; 81: 784-787. Jonga i-abstract.
  124. UZsivkovits, M., Fekadu, K., Sontag, G., Nabinger, U., Huber, WW, Kundi, M., Chakraborty, A., Foissy, H., kunye noKnasmuller, S. Uthintelo lwe-heterocyclic amine-indened. Umonakalo we-DNA kwikholoni kunye nesibindi seempuku ziindidi ezahlukeneyo ze-lactobacillus. ICarcinogenesis 2003; 24: 1913-1918. Jonga i-abstract.
  125. I-Orrhage, K., Sjostedt, S., kunye neNord, C. E. Iziphumo zokuncedisa nge-lactic acid bacteria kunye ne-oligofructose kwi-microflora yamathumbu ngexesha lolawulo lwe-cefpodoxime proxetil. J Antimicrob. Umama. Ngo-2000; 46: 603-612. Jonga i-abstract.
  126. UXiao JZ, Takahashi S, Odamaki T, et al. Ukuchaphazeleka kwe-Antibiotic ye-bifidobacterial strains ezisasazwe kwimarike yaseJapan.Biosci Biotechnol Biochem. Ngo-2010; 74: 336-42. Jonga i-abstract.
  127. IAlFaleh K, Anabrees J, Bassler D, Al-Kharfi T.Iiprobiotiki zokuthintela i-necrotizing enterocolitis kwiintsana ezizelwe ngaphambi kwexesha. Isiseko sedatha yeCochrane yoPhononongo olucwangcisiweyo luka-2011, uMba we-3. Hayi: CD005496. INGXELO: 10.1002 / 14651858.CD005496.pub3. Jonga i-abstract.
  128. Iitheyibhuli zeMM, iMilliano I, iRoseboom MG, iBenninga MA. Ngaba iBifidobacterium breve iyasebenza kunyango lokuqhinwa kwabantwana? Iziphumo ezivela kufundo lokuqhuba. Isondlo J 2011; 10: 19. Jonga i-abstract.
  129. U-Leyer GJ, uLi S, uMubasher ME, et al. Iziphumo zeprobiotic kubanda kunye neempawu zomkhuhlane ezifana neziganeko kunye nexesha kubantwana. Iipedatifikethi 2009; 124: e172-e179. Jonga i-abstract.
  130. UMiele E, uPascarella F, uGiannetti E. et al. Iziphumo zokulungiselela iprobiotic (VSL # 3) kuqeqesho kunye nokugcinwa kokuxolelwa kubantwana abane-ulcerative colitis. NdinguJ Gastroenterol 2009; 104: 437-43. Jonga i-abstract.
  131. UKuhbacher T, Ott SJ, uHelwig U, et al. I-bacterial and fungal microbiota ngokunxulumene nonyango lweprobiotic (VSL # 3) kwi-pouchitis. Umjelo 2006; 55: 833-41. Jonga i-abstract.
  132. IBibiloni R, uFedorak RN, uTannock GW, et al. Umxube we-VSL # 3 we-probiotic-induces uxolelo kwizigulana ezine-ulcerative colitis. NdinguJ Gastroenterol 2005; 100: 1539-46. Jonga i-abstract.
  133. UTursi A, uBrandimarte G, uGiorgetti GM, et al. I-balsalazide yedosi ephantsi kunye nokulungiswa okuphezulu kwe-probiotic kusebenza ngakumbi kune-balsalazide yodwa okanye i-mesalazine kunyango lwe-ulcerative colitis. IMed Sci Monit 2004; 10: PI126-31. Jonga i-abstract.
  134. UKato K, uMizuno S, Umesaki Y, et al. Uvavanyo olulawulwa ngokungaqhelekanga lwe-placebo oluvavanya isiphumo sobisi lwe-bifidobacteria-enegwele kwi-ulcerative colitis esebenzayo. Ukudibana kweFarmacol Ther 2004; 20: 1133-41. Jonga i-abstract.
  135. IMcFarland LV. Uhlalutyo lwe-meta lweeprobiotic zokuthintela isifo esihambisa isifo esihambisa isifo kunye nokunyanga isifo seClostridium difficile. NdinguJ Gastroenterol 2006; 101: 812-22. Jonga i-abstract.
  136. U-O'Mahony L, uMcCarthy J, uKelly P, okqhubekayo. I-Lactobacillus kunye ne-bifidobacterium kwisifo sengqondo sesilonda: iimpendulo zempawu kunye nolwalamano kwiiprofayili ze-cytokine. I-Gastroenterology 2005; 128: 541-51. Jonga i-abstract.
  137. Ishikawa H, Akedo I, Umesaki Y, et al. Uvavanyo olulawulwa ngokungahleliwe lwesiphumo sobisi lwe-bifidobacteria-olunencindi kwi-ulcerative colitis. J NdinguColl Nutrt 2003; 22: 56-63. Jonga i-abstract.
  138. Rastall RA. Iibacteria emathunjini: izihlobo neentshaba kunye nendlela yokutshintsha ibhalansi. J Amanqatha 2004; 134: 2022S-2026S. Jonga i-abstract.
  139. UMimura T, uRizzello F, uHelwig U, et al. Kanye unyango lweedosi oluphezulu lwe-probiotic (VSL # 3) yokugcina uxolelo kwi-pouchitis ephindaphindayo okanye ephikisayo. Isisu 2004; 53: 108-14. Jonga i-abstract.
  140. ICremonini F, uDi Caro S, uCovino M, et al. Ukuxhamla Iziphumo zamalungiselelo ahlukeneyo eproticotic kwi-anti-helicobacter pylori yeziphumo ezinxulumene nonyango: iqela elifanayo, iimfama ezintathu, isifundo esilawulwa yi-placebo. NdinguJ Gastroenterol 2002; 97: 2744-9. Jonga i-abstract.
  141. USullivan A, uBarkholt L, uNord CE. I-Lactobacillus acidophilus, i-Bifidobacterium lactis kunye ne-Lactobacillus F19 kuthintela ukuphazamiseka kwendalo okunxulumene ne-bacteriides fragilis emathunjini. J Iantimicrob Chemother 2003; 52: 308-11. Jonga i-abstract.
  142. UKim HJ, uCamilleri M, McKinzie S, et al. Uvavanyo olulawulwa ngokungenamthetho lweprobiotic, i-VSL # 3, kwindlela yokuhamba kwamathumbu kunye neempawu zorhudo-ubukhulu becala isifo samathumbu. Ukudibana kweFarmacol Ther 2003; 17: 895-904. . Jonga i-abstract.
  143. Roberfroid MB. Ii-prebiotic kunye neprobiotic: ngaba kukutya okusebenzayo? NdinguJ J Clin 2000; 71: 1682S-7S. Jonga i-abstract.
  144. UGionchetti P, uRizzello F, uVenturi A, et al. I-bacteriotherapy yomlomo njengonyango lolondolozo kwizigulana ezine-pouchitis enganyangekiyo: ityala elilawulwa kabini, elingaboniyo. I-Gastroenterology 2000; 119: 305-9. Jonga i-abstract.
  145. URautio M, uJousimies-Somer H, uKauma H, okqhubekayo. Ithumba lesibindi ngenxa ye-Lactobacillus rhamnosus strain engabonakaliyo kuL. Rhamnosus strain GG. Iiklinikhi ezichaphazela iDis 1999; 28: 1159-60. Jonga i-abstract.
  146. IGoldin BR. Izibonelelo zezeMpilo zeprobiotic. Br J Amanqaku 1998; 80: S203-7. Jonga i-abstract.
  147. UKalima P, Masterton RG, uRoddie PH, et al. I-Lactobacillus rhamnosus usulelo kumntwana emva kokufakwa komongo wethambo. J Ukuchaphazela i-1996; 32: 165-7. Jonga i-abstract.
  148. USaxelin M, uChuang NH, uChassy B, et al. ILactobacilli kunye nebacteremia kumazantsi eFinland 1989-1992. Iiklinikhi ezichaphazela iDis 1996; 22: 564-6. Jonga i-abstract.
  149. U-Lewis SJ, uFreedman AR. Ukuphononongwa kwinqaku: ukusetyenziswa kweearhente zonyango kuthintelo kunye nonyango lwezifo zesisu. Ukudibana kweFarmacol Ther 1998; 12: 807-22. Jonga i-abstract.
  150. Meydani SN, Ha WK. Iziphumo ze-Immunologic yeyogathi. NdinguJ J Clin 2000; 71: 861-72. Jonga i-abstract.
  151. UIsolauri E, Arvola T, Sutas Y, et al. Iiprobiotic kulawulo lwe-atopic eczema. Iiklinikhi ze-Exp Allergy 2000; 30: 1604-10. Jonga i-abstract.
  152. I-Korschunov VM, i-Smeyanov VV, i-Efimov BA, okqhubekayo. Ukusetyenziswa konyango lwe-Bifidobacterium enganyangekiyo ngamayeza emadodeni avezwe kwidosi ephezulu ye-gamma-irradiation. IJ Med Microbiol 1996; 44: 70-4. Jonga i-abstract.
  153. UVenturi A, uGionchetti P, uRizzello F, et al. Impembelelo ekwakhiweni kweentyatyambo zelindle ngamalungiselelo amatsha eprobiotic: idatha yokuqala yonyango lokugcinwa kwabaguli abane-ulcerative colitis. Ukudibana kweFarmacol Ther 1999; 13: 1103-8. Jonga i-abstract.
  154. UPhuapradit P, uVaravithya W, uVathanophas K, et al. Ukuncitshiswa kosulelo lwe-rotavirus kubantwana abafumana ifomula eyongezelelweyo ye-bifidobacteria. UJ Med Assoc Thai 1999; 82: S43-8. Jonga i-abstract.
  155. IHoyos AB. Ukuncipha kweziganeko ze-necrotizing enterocolitis enxulunyaniswa nolawulo lwangaphakathi lweLactobacillus acidophilus kunye neBifidobacterium infantis kwii-neonates kwiyunithi yonyango olunzulu. I-Int J Ingena kwi-Dis 1999; 3: 197-202. Jonga i-abstract.
  156. UPierce A. Umbutho oSebenzayo woNyango waseMelika kwiNyango yeNdalo. ENew York: I-Stonesong Press, ngo-1999: 19.
  157. UChen RM, uWu JJ, uLee SC, et al. Ukonyuka kwe-Bifidobacterium yamathumbu kunye nokucinezelwa kweebacteria ze-coliform ezinokungenisa i-yogurt yexesha elifutshane. J Dairy Sci 1999: 82: 2308-14. Jonga i-abstract.
  158. Ha GY, Yang CH, Kim H, Chong Y. Imeko ye-sepsis ebangelwa yi-Bifidobacterium longum. J Iklinikhi yeMicrobiol 1999; 37: 1227-8. Jonga i-abstract.
  159. IColombel JF, iCortot A, iNutut C, iRomond C.Iyogathi kunye neBifidobacterium longum inciphisa iziphumo zesisu ezibangelwa yi-erythromycin. ILancet 1987; 2: 43.
  160. Hirayama K, Rafter J. Indima yeeproticotic kuthintelo lomhlaza. Iintsholongwane ezichaphazelekileyo 2000; 2: 681-6. Jonga i-abstract.
  161. IMacfarlane GT, iCummings JH. Iiprobiotic kunye nee-prebiotic: ngaba ukulawula imisebenzi yebacteria yamathumbu kuyanceda kwimpilo? BMJ 1999; 318: 999-1003. Jonga i-abstract.
  162. UChiang BL, uSheih YH, uWang LH, et al. Ukuphucula ukukhuselwa komzimba kukutya okusetyenzisiweyo kwintsholongwane ye-lactic acid bacterial (Bifidobacterium lactis HN019): ukwenziwa kunye nenkcazo yeempendulo zamaseli omzimba. I-Eur J yeklinikhi yeNutriti 2000; 54: 849-55. Jonga i-abstract.
  163. ULievin V, uPeiffer I, uHudault S, et al. Iintlobo ze-Bifidobacterium ezivela kumntwana osesiswini womntu microflora zenza umsebenzi we-antimicrobial. Umjelo 2000; 47: 646-52. Jonga i-abstract.
  164. Arunachalam K, Gill HS, Chandra RK. Ukuphuculwa kokusebenza komzimba wamajoni omzimba ngokusetyenziswa kokutya kweBifidobacterium lactis (HN019). I-Eur J yeklinikhi yeNutriti 2000; 54: 263-7. Jonga i-abstract.
  165. UBouhnik Y, Pochart P, uMarteau P, et al. Ukubuyela kwimeko yesiqhelo ebantwini kwi-bifidobacterium efanelekileyo efakwe kubisi olunotyiweyo. I-Gastroenterology 1992; 102: 875-8. Jonga i-abstract.
  166. Saavedra JM, okqhubekayo. Ukondla i-bifidobacterium bifidum kunye ne-streptococcus thermophilus kwiintsana esibhedlele kuthintelo lohudo kunye nokuphalaza i-rotavirus. ILancet 1994; 344: 1046-9. Jonga i-abstract.
  167. I-Scarpignato C, i-Rampal P. Uthintelo kunye nonyango lotyatyazo lomhambi: Indlela yeklinikhi yokuthambisa. I-Chemotherapy ngo-1995; 41: 48-81. Jonga i-abstract.
  168. I-Elmer GW, iSurawicz CM, iMcFarland LV. Iiarhente zeBiotherapeutic, indlela etyeshelweyo yonyango kunye nothintelo losulelo olukhethiweyo lwamathumbu kunye nolwangasese. IJAMA 1996; 275: 870-5. Jonga i-abstract.
Ukuhlaziywa kokugqibela-11/25/2020

Isabelo

IBS kunye ne-Weight Gain okanye i-Loss
Zempilo

IBS kunye ne-Weight Gain okanye i-Loss

i ifo e injani e ilonda?Irritable bowel yndrome (IB ) yimeko ebangela ukuba umntu abe neempawu ezingathandekiyo ze i u (GI) rhoqo. Oku kunokubandakanya:ukuxinwa i i uintlunguurhudoukuqhinairha iukudu...
Yintoni enokubangela iintlungu ezisezantsi kwabaseTyhini?
Zempilo

Yintoni enokubangela iintlungu ezisezantsi kwabaseTyhini?

Intlungu e ezant i yomqolo kubafazi inezizathu ezininzi ezinokubangela. Ezinye zihambelana neemeko ezithile kwaba etyhini, ngelixa ezinye zinokwenzeka nakubani na. Kule nqaku, iza kujonga ngakumbi izi...